KLTO
Klotho Neurosciences, Inc.NASDAQHealthcare$0.38-7.10%ClosedMarket Cap: $20.1M
As of 2026-04-04
Valuation
P/E (TTM)
—
PEG
—
P/B
—
P/S
—
EV/EBITDA
—
DCF Value
$-0.01
FCF Yield
—
Div Yield
—
Margins & Returns
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
—
ROA
—
ROIC
—
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $0.00 | NaN% | $-1.9M | $-2.9M | $-0.05 | — |
| Q2 2025 | $0.00 | NaN% | $-1.9M | $-4.1M | $-0.12 | — |
| Q1 2025 | $0.00 | NaN% | $-1.6M | $-2.2M | $-0.08 | — |
| Q4 2024 | $0.00 | NaN% | $-1.9M | $-2.1M | $-0.08 | — |
| FY 2024 | $0.00 | NaN% | $-5.5M | $-6.2M | $-0.32 | — |
| Q3 2024 | $0.00 | NaN% | $-2.9M | $-3.0M | $-0.18 | — |
| Q2 2024 | $0.00 | NaN% | $-395.6K | $-451.6K | $-0.03 | — |
| Q1 2024 | $0.00 | NaN% | $-672.0K | $-672.0K | $-0.00 | — |
| Q4 2023 | $0.00 | NaN% | $-110.7K | $-126.5K | $-0.01 | — |
| FY 2023 | $0.00 | NaN% | $-631.3K | $-707.5K | $-0.00 | — |
| Q3 2023 | $0.00 | NaN% | $-123.7K | $-144.1K | $-0.00 | — |
| Q2 2023 | $0.00 | NaN% | $-244.3K | $-264.4K | $-0.02 | — |